Vice Chair, Dept of Urology; Director of Reconstruction and Prosthetics
Fox Chase Cancer Center
Dr. Jay Simhan is Vice Chair, Professor of Urology and Director of Reconstructive Urology at Temple Health and the Fox Chase Cancer Center. Additionally, he serves as Fellowship Director of the Society of GURS verified Male Reconstruction and Prosthetic Urology Program at Fox Chase.
Dr. Simhan graduated summa cum laude with highest honors and a BS degree in Chemistry from the UNC-Chapel Hill. After also obtaining his medical degree at UNC, he completed General Surgery and Urology residencies at Temple University Hospital and Fox Chase in Philadelphia, Pennsylvania. He completed additional fellowship training in Urologic Trauma, Reconstruction, and Prosthetics at the University of Texas Southwestern in Dallas, Texas. Dr. Simhan has completed additional executive leadership training at the Wharton School at the University of Pennsylvania. He is an active and contributing member of the American Urologic Association, American College of Surgeons, Society of Genitourinary Reconstructive Surgeons (GURS), Société Internationale d’Urologie, Society of Urologic Prosthetic Surgeons, and the Sexual Medicine Society of North America. He currently serves as a member of the Board of Directors of the GURS.
Dr. Simhan’s clinical practice is dedicated to urethral stricture disease, open and robotic urinary tract reconstruction, penile implant surgery, male anti-incontinence surgery, revision male prosthetic surgery, Peyronie’s disease, and complications from urologic cancer treatment. He has lectured internationally on a variety of topics in urologic reconstruction, trauma, and prosthetics and is an invited international proctor for training programs in prosthetic urology. He has published chapters in many leading textbooks, including the definitive chapter on lower urinary tract trauma in the gold-standard textbook, Campbell-Walsh-Wein Urology. Dr. Simhan has co-authored over 250 peer-reviewed publications, abstracts, and book chapters in leading journals including the Journal of Urology, Urology, European Urology, and the Journal of Sexual Medicine.
Disclosure information not submitted.
Friday, April 28, 2023
3:10 PM – 3:25 PM CST